What Is Sarcopenia? — A Muscle Account Filled and Drawn Every Day, and Strength That Drains Faster Than the Balance

The Phrase "My Legs Have No Strength"

A seventy-six-year-old mother returns home after a week of hospitalization. When getting up from a chair, she leans on the armrests, and she catches her breath at a few steps in front of the apartment entrance. Before hospitalization, she used to walk to the market carrying a shopping cart. Two thoughts cross her child's mind: "That's just how it is when you get old," and the thought that they should perhaps prepare more meat or protein for her.

One name that can be attached to this appearance is sarcopenia. Sarcopenia is a state where the mass, strength, and function of muscles decrease together as we age. It is common in older people but can also occur at earlier ages (PMID 30312372), and it arises due to reduced movement, poor nutrition, or other illnesses (PMID 40218995). This article starts from how muscles are maintained, and looks in turn at a few days of bed rest, age, how to measure sarcopenia, and the evidence for exercise and diet.

What Do Muscles Do?

The strength to raise an arm, climb stairs, and get up from a chair all comes from muscles. Skeletal muscles are muscles attached to bones that move our bodies as we intend. Muscle fibers are the thin, long cells that make up a muscle, and these gather in bundles to form a single muscle.

Skeletal muscle is the largest organ in the body by weight (PMID 32940941). Muscle takes care of 80% of the glucose gathered from the blood after a meal (PMID 32940941).

Insulin is a hormone released by the pancreas when blood sugar rises, telling the liver, muscles, and fat to "gather and store the glucose in the blood." Muscle is the main tissue that gathers glucose upon receiving insulin signals, and after contracting muscles, they become more sensitive to subsequent insulin signals (PMID 33826918). Obesity is a state where fat has accumulated excessively in the body. In obesity and type 2 diabetes, one of the reasons glucose is not processed well is that muscles fail to properly gather glucose, which is currently being studied (PMID 33826918).

Muscle is an organ that moves the body while also being the tissue that gathers the most sugar from the blood after a meal.

A Bank Account That Fills and Empties Every Day

Muscles are constantly being newly built and torn down. Muscle protein synthesis is the process by which muscle builds new protein and adds it to its own body. Muscle protein breakdown is the process by which muscle tears down protein it already possesses. The biggest factor determining the amount of muscle is the balance between these two (PMID 35476500).

The signals that shift this balance every day are physical activity and eating (PMID 30048806). Comparing it to a bank account, synthesis is a deposit, breakdown is a withdrawal, and the amount of muscle is the balance.

As people age, changes occur in this account. There is little evidence that usual synthesis and breakdown themselves change in aging muscle; rather, becoming less responsive to the signals of physical activity and eating is cited as the basis for age-related muscle loss (PMID 30048806). Anabolic resistance is a state where aging muscle does not respond as much as young muscle to signals like exercise or meals that say "build." In terms of a bank account, it is like having less money come in even when you put in the same deposit request. Older individuals with anabolic resistance are prone to experiencing greater muscle loss when facing periods of reduced movement (PMID 35476500).

The analogy holds true only up to the amount of muscle. A bank account balance is just a single number, but muscle has strength that moves alongside its amount yet cannot be fully explained by the amount alone.

The amount of muscle is determined by the difference between the side that builds daily and the side that tears down, and the signals that shift that balance are physical activity and eating.

A Few Days of Lying Down Changes Everything

When you spend your days lying in bed, the strength and size of the quadriceps—the large muscles on the front of the thigh that support your body weight—drop the fastest in the early days after lying down, after which the rate of decline slows down. This is the result of an analysis pooling data from 318 healthy adults who spent between 5 and 120 days lying down in experiments (PMID 33703945). During the first two weeks, strength decreased much faster than muscle size (PMID 33703945). About 79% of the strength lost during bed rest was explained by the reduction in muscle mass, while the remainder is attributed to changes in the properties of nerves and muscle fibers (PMID 33703945). The authors noted that even a short hospital stay of 5 days or fewer is enough to noticeably reduce muscle mass and size and weaken maximum strength (PMID 33703945).

Muscle atrophy is when muscles become thinner and shrink. Using muscles less or reducing the weight placed on them are major external factors that drive muscle atrophy (PMID 35476500). When illness wears down the body, changes in hormones and inflammation can compound this and accelerate muscle atrophy (PMID 35476500). Inflammation is a response in which the body summons immune cells, swells the affected area, and reacts against stimuli such as injury, infection, or substances introduced from outside the body. In terms of a bank account, lying down is like reducing your deposits. Short periods of bed rest or disuse drop muscle protein synthesis, quickly eroding muscle mass and function alongside the ability to process glucose (PMID 27376322).

In older adults, this magnitude is even greater. In an analysis pooling experiments where 118 healthy older volunteers spent 5 to 14 days lying down, fat-free body weight decreased by an average of 1.5 kg. In the same analysis, older adults lost more leg muscle than the younger adults compared alongside them (0.86 kg versus 0.24 kg) (PMID 34422875). Knee extension strength dropped significantly, and the longer they lay down, the more it dropped (PMID 34422875).

These numbers came from experiments where healthy volunteers intentionally lay down. If illness is wearing down the body, the hormonal and inflammatory changes we saw earlier can add to this (PMID 35476500).

Just a few days of lying down visibly reduces muscle and strength, this decline is fastest in the first few days, and it is greater in older adults.

Mass and Strength That Decrease With Age

When muscle mass decreases in older adults, leg strength decreases along with it, but strength decreases about three times faster. When 1,880 people were followed for 3 years, leg strength decreased by 2.6 to 4.1% each year, while leg muscle mass decreased by about 1% each year (PMID 17077199). Strength here refers to muscular strength. Muscular strength is the force that can be exerted by voluntarily contracting muscles. In the same study, people who maintained or increased their muscle mass could not prevent their muscular strength from decreasing (PMID 17077199).

Muscle mass begins to decrease by around 1% each year starting in middle age, and in severe cases, nearly half of it is lost by the eighties and nineties (PMID 30048806). The thinning of individual muscle fibers and the decrease in the number of muscle fibers itself happen together (PMID 30048806). Studies that measured both mass and strength in the same people report that muscular strength decreases 2 to 5 times faster than muscle mass (PMID 22934016).

Comparing this to a bank account, while the balance decreases slightly, strength drains out several times faster. This is precisely what the analogy fails to capture. Researchers interpret this to mean that the force produced by a muscle of the same size—in other words, muscle quality—declines (PMID 17077199, PMID 22934016). Some researchers argue that the causes of declining strength should be sought more in the properties of muscle contraction or changes in nerves rather than in muscle mass (PMID 18772470).

Strength is also what better tells us about future health. In a study that followed 2,292 people in their seventies for an average of 4.9 years, leg strength and grip strength were strongly associated with death, whereas muscle size was not strongly associated with death (PMID 16456196). Even when pooling multiple studies, it is the decrease in muscular strength rather than muscle mass that more consistently leads to the risks of disability and death (PMID 22934016).

What tilts the balance toward breakdown? In older adults, a lack of exercise, insufficient nutrition, and hormonal changes overlap, causing the breakdown of muscle protein to outpace its synthesis (PMID 34184088). The decline of nerves, inflammatory responses, chronic illnesses, and fat accumulating within muscles are also cited as causes (PMID 22955023).

Aging comes to everyone, but not everyone experiences it to the same degree. An expert consensus on exercise in older adults published by the International Conference on Frailty and Sarcopenia Research (ICFSR) views aging and the decline of bodily function as inevitable, yet notes that the face of aging splits between two extremes depending on how one lives, especially whether one moves the body, and that with sufficient exercise and physical activity, the age-related decline in muscle function and cardiorespiratory function is considerably blunted (PMID 34409961).

With age, muscle mass and strength decrease together, but strength decreases several times faster than mass, and strength is also what better tells us about future health.

How Sarcopenia Is Measured

The tools to measure strength and body movement are simple. They are a hand-held measuring device, a chair, and a few meters of hallway. To confirm sarcopenia, muscle mass is also measured separately using X-ray equipment or a device that passes a weak electrical current through the body (PMID 32033882). Grip strength is the force exerted when squeezing something tightly with the hand. Grip strength can be reliably measured with a hand-held measuring device (PMID 38195493). Physical performance is a measured value of how well a person accomplishes tasks using their entire body, such as walking or rising from a chair. Examples include walking speed and the time it takes to rise from a chair five times (PMID 32033882).

The initial criteria published by the European Working Group on Sarcopenia in Older People (EWGSOP) in 2010 considered both low muscle mass and low muscle function to be required for a diagnosis of sarcopenia (PMID 20392703). The revised criteria gathered and released in 2018 (EWGSOP2) changed the order. They place low muscle strength as the core characteristic of sarcopenia, confirm the diagnosis with low muscle mass or quality, and view poor physical performance as an indicator of severe sarcopenia (PMID 30312372). The same document defines sarcopenia as a muscle disease (PMID 30312372).

<!-- FIG: The order of EWGSOP2 — ① Measure strength with grip strength and chair stands → ② Confirm with muscle mass and quality → ③ Classify severity with physical performance such as walking speed. The main point is that strength comes in the first box -->

The evidence supporting the approach of looking at strength first goes beyond what we saw in the previous section. Lean mass is the remaining weight of the body after subtracting fat. When the Sarcopenia Definition and Outcomes Consortium (SDOC), a group of researchers, analyzed community-dwelling older adult data in 2020, low grip strength and slow gait each predicted falls, self-reported mobility limitation, hip fracture, and death, whereas lean mass measured by X-ray equipment was not associated with these outcomes (PMID 32150289).

The Asian Working Group for Sarcopenia (AWGS) gathered research data from Asia to establish separate criteria (PMID 24461239). The criteria revised in 2019 designated even just one of either low strength or low physical performance as "possible sarcopenia," allowing lifestyle interventions to be initiated earlier in local primary care settings (PMID 32033882). The threshold values for grip strength also vary by population, and are lower in Asian people and women (PMID 38195493).

Therefore, how common sarcopenia is also varies depending on the criteria used. In an analysis pooling data from approximately 690,000 people, the proportion of sarcopenia in those aged 60 and older ranged from 10% to 27% depending on the criteria (PMID 34816624). In the same analysis, using EWGSOP2 yielded a higher proportion in men (11% versus 2%), whereas using another international criterion (IWGS) yielded a higher proportion in women (17% versus 12%) (PMID 34816624). Even which sex has more cases is inverted simply by changing the criteria.

The Global Leadership Initiative in Sarcopenia (GLIS), a gathering of various international societies, established a universal conceptual definition for the world for the first time in 2024. It accepted muscle mass, muscle strength, and strength relative to muscle mass as components of sarcopenia, while viewing the decline in physical performance as an outcome rather than a component (PMID 38520141). Based on the 2024 document, common criteria to be actually used in clinical practice and research were being developed based on this definition (PMID 38520141).

Sarcopenia is measured by first assessing strength and confirming with muscle mass, and because there are multiple criteria, the exact percentage of people with sarcopenia varies greatly depending on which criteria are used.

Links to Falls, Fractures, and Death

The risk of death in people with sarcopenia appears to be roughly twice that of people without it. This is the result of pooling data from 56 studies involving some 42,000 people (PMID 34315158). This association held true regardless of whether groups such as community-dwelling residents, outpatients, inpatients, or nursing home residents were looked at separately, and regardless of which criteria were used (PMID 34315158).

These numbers came from observational studies. Observational studies are research where people's lives are not touched; they are left to live as they normally do, and what happens afterward is watched. While observational studies show that sarcopenia and death go together, whether sarcopenia caused that death is a separate question to be asked. When analyses gathering the associations of sarcopenia with various poor outcomes are gathered again, the quality of most of the evidence is rated as low or very low (PMID 32924316). Based on these associations, various academic society documents recommend looking for older adults at risk of sarcopenia in clinical practice and diagnosing it early (PMID 34315158, PMID 30312372, PMID 39838543).

A fall is an event resulting in a person unintentionally coming to rest on the ground, floor, or other lower level. The GLIS outcome working group considered the level of evidence to be high for the association of sarcopenia with reduced quality of life, falls and fractures, and death (PMID 40120052). The association with reductions in activities necessary to live independently, such as grocery shopping or housework, was moderate, and the evidence was insufficient to draw a conclusion regarding associations with hospitalization, admission to long-term care facilities, mobility disability, and basic activities of daily living such as dressing or bathing (PMID 40120052). The working group attributed this reason to the scarcity of studies followed for a long time.

Frailty is a state where physical and cognitive strengths decline together, accompanied by weight loss, easy fatigue, reduced movement, weakened muscle strength, and slowed walking. Sarcopenia is considered a major component of frailty (PMID 30176345). The frailty guideline used as evidence in this article deals with physical frailty among them (PMID 31641726).

There are also matters distinct from slow changes according to age. Muscles shrink not only from reduced movement and poor nutrition, but also due to hormone abnormalities, diseases of the nervous system, inflammation, and wasting diseases that break down the body (PMID 40218995). The international clinical practice guideline for frail older adults strongly recommends looking for treatable causes in frail people who are losing weight, and examining causes such as depression, anemia, low blood pressure, hypothyroidism, and vitamin B12 deficiency in those who tire easily (PMID 31641726). When body weight or strength visibly drops, it may be due to these other illnesses rather than just reduced movement, so the cause is sought through medical exams and tests before writing it off as just aging.

It has been repeatedly confirmed through observational studies that sarcopenia goes hand in hand with falls, fractures, and death, but that association does not mean causation.

Even Aging Muscles Respond

The muscles of people over eighty also grow stronger when given work (PMID 32740889). Resistance exercise is exercise that provides a weight that the muscle must push against, such as gym equipment or one's own body weight, and is commonly called strength training. A randomized controlled trial is a study that divides participants randomly, like a draw, applies a certain intervention to only one side, and compares the results with the other side. When 22 randomized controlled trials gathering only those aged 75 and older were analyzed, strength training increased both muscle strength and muscle size, and strength increased even when looking separately at those aged 80 and older (PMID 32740889). In the same analysis, grip strength did not show a clear difference between the exercised side and the unexercised side (PMID 32740889).

In a Cochrane review combining 121 trials involving 6,700 older adults, progressive resistance training significantly increased muscle strength (PMID 19588334). The ability to rise from a chair improved by a moderate to large degree, walking speed became slightly faster by about 0.08 meters per second, and overall physical ability improved by a small but clear margin (PMID 19588334). Adverse events were not properly recorded in many trials. In the trials that did record them, joint pain and muscle soreness were commonly reported, serious adverse events were rare, and none were reported as directly related to exercise. The authors added that caution is needed when translating this exercise to people with illnesses (PMID 19588334).

The evidence gathering only people with sarcopenia is much scarcer than that for healthy older adults (PMID 35150587). In an analysis combining 23 trials of 1,252 older adults with sarcopenia, exercise increased grip strength (average 2.38 kg), leg strength, walking speed, and mobility, and slightly increased leg muscle mass, but did not clearly increase total body muscle mass, combined limb muscle mass, or arm muscle mass (PMID 35805870). Programs mixing resistance exercise and various exercises increased strength, whereas aerobic exercise alone did not (PMID 35805870).

Evaluations are divided regarding the magnitude of benefit. An analysis combining 42 trials and 3,728 participants found that, when followed for a median of 12 weeks, resistance exercise (with or without added nutrition) and mixed routines of resistance, aerobic, and balance exercise improved quality of life the most compared to usual care, and the certainty of that evidence was high or moderate (PMID 37057640). On the other hand, another 2025 analysis (24 trials, 951 participants) concluded that while resistance exercise is likely to increase strength and physical function, the degree of improvement does not exceed the minimum size for a patient to perceive a difference, so there may be little to no clinical benefit (PMID 41212331).

The number stating that muscle mass has increased and the fact that daily life has improved are different things. In sarcopenia trials, strength and function moved more consistently than muscle mass (PMID 35805870). The distance between numbers and life is covered in "Better Numbers, Better Patients? — An Introduction to Surrogate Endpoints".

Resistance exercise is the center of sarcopenia treatment, but it does not suit everyone (PMID 39300120). International clinical guidelines addressing frailty strongly recommend multi-component physical activity programs including resistance exercise as the first treatment for managing frailty (PMID 31641726). The stance of the ICFSR consensus is that the type and amount of exercise should be determined and adjusted individually for each person according to their goals and health status (PMID 34409961). The question of how much to do continues in "How Much Is Enough — An Introduction to Dose-Response in Rehabilitation".

Even past eighty, muscles respond to resistance exercise and grow stronger, but evaluations vary across analyses as to whether the benefit in people with sarcopenia is large enough to be felt in daily life.

The Places of Diet and Medicine

Eating is one of the two signals that drive muscle protein synthesis (PMID 30048806). In an analysis pooling 74 randomized controlled trials in healthy adults, eating more protein slightly increased fat-free mass and leg strength in people who also did resistance training, and the magnitude was small (PMID 35187864). The effect on physical function tests like walking was very small, and the effect on grip strength was unclear (PMID 35187864).

A review by the Belgian Society of Gerontology and Geriatrics, re-pooling reviews covering adults aged 65 and older, noted that the level of evidence was mostly low to moderate (PMID 32483625). The one with the best-supported evidence was supplementation with the amino acid leucine, which was evidence regarding muscle mass in older adults with sarcopenia. Adding protein supplementation on top of resistance training was recommended for increasing muscle mass and strength, particularly for people with obesity and when sustained for 24 weeks or longer. Whether sarcopenia itself improved was not reported by the included reviews (PMID 32483625).

The frailty guidelines conditionally recommended protein and calorie supplementation for frail people who are losing weight or undernourished, and made no recommendation for vitamin D supplementation (PMID 31641726). There are also review articles that highlight ensuring adequate protein and vitamin D as the center of treatment alongside resistance training (PMID 28689564). Put into bankbook terms, the benefit of eating more protein in healthy adults was confirmed mainly when accompanied by the deposit signal of resistance training, and its magnitude was small (PMID 35187864).

What about medicine? As of a 2022 review, there were no drugs approved by the US Food and Drug Administration (FDA) for the treatment of sarcopenia, and although various classes of drugs have been tested, their effects have been inconsistent (PMID 35535373). The ICFSR consensus notes that in a state where there is no effective drug treatment like for sarcopenia, exercise can stand in the primary place for prevention and treatment (PMID 34409961).

The evidence for protein and nutritional supplementation is mixed, recommendations come with conditions such as being paired with resistance training or for frail individuals who are losing weight or undernourished, and no drugs have been approved.

When Fat Is Abundant and Muscle Is Scarce

People who weigh a lot can still lack muscle. Even in people with obesity, a sedentary lifestyle, abnormalities in adipose tissue, comorbid conditions, and aging commonly cause the mass and function of muscle to decrease (PMID 35196654). Sarcopenic obesity is the coexistence of excessively high body fat and low muscle mass and function.

A consensus by the European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO) suggests measuring muscle function first and then body composition to confirm high fat and low muscle (PMID 35196654). The same consensus statement notes that due to a lack of a unified definition, it has been difficult to determine how common and how harmful sarcopenic obesity is (PMID 35196654).

With the advent of new obesity drugs that significantly reduce body weight, whether muscle is lost alongside fat has become a question. When weight is reduced with these drugs, fat-free mass also clearly decreases to varying degrees, how much this affects muscle mass and function remains uncertain, and its clinical significance is debated (PMID 40296814). This review considers that adequate protein intake and structured exercise, especially strength training, play an important role in reducing this loss (PMID 40296814). How these drugs work is covered in What Are Obesity and GLP-1 Drugs? — A Letter That Lingers, a Weight That Wants to Return.

Sarcopenic obesity is confirmed by measuring muscle function first and then body composition, and the significance of muscle loss during weight reduction is still debated.

Mother, Discharged and Again

Let us return to Mother as she was at first. During her week of hospitalization, she was mostly in bed. In bed-rest experiments with healthy volunteers, muscle and strength shrank the fastest in the beginning, and researchers considered a short hospital stay of five days or less to be enough for a clear loss of muscle (PMID 33703945). The leg muscles of older volunteers shrank more than those of younger people (PMID 34422875). If Mother's illness was of the kind that wears down the body, changes in hormones and inflammation may have added to it (PMID 35476500).

The saying "it happens to everyone as they get older" is only half right. The decline in muscle function with age comes to everyone, but its extent varies depending on whether one moves the body (PMID 34409961), and strength training increased muscle strength even in people over eighty (PMID 32740889). However, whether that benefit is large enough to feel in daily life for people with sarcopenia is debated (PMID 41212331), and strength training does not suit everyone (PMID 39300120).

Whether one has sarcopenia is first checked by measuring strength with grip strength or chair stands, and confirmed with equipment that measures muscle mass, though the diagnosis can change depending on the criteria used (PMID 30312372, PMID 32033882, PMID 34816624). Whether to check for sarcopenia is a question you can ask during a clinic visit. If weight has dropped significantly, it may not be solely due to moving less, so the cause is investigated (PMID 40218995). International guidelines for frail older adults conditionally recommend protein and calorie supplementation for frail people who have lost weight or are undernourished (PMID 31641726). The confirmed benefits of eating extra protein were mainly seen in healthy adults who also did strength training, and the magnitude was small (PMID 35187864). A review by the Belgian Society of Gerontology and Geriatrics recommended adding protein supplementation on top of strength training, but the quality of evidence was mostly low to moderate, and effects on sarcopenia itself were not reported (PMID 32483625). Which of these to apply to Mother and how is a matter to decide with her doctor in the clinic.

Where to Look Further

The universal diagnostic criteria were being shaped into a form for clinical use based on a 2024 document (PMID 38520141), and whether the benefits of exercise in people with sarcopenia are large enough to be felt in daily life also varies by analysis (PMID 41212331). To clarify what causes sarcopenia, more studies that follow people over a long period and interventional studies are needed (PMID 40718350).

The story that bone is also a tissue that becomes sturdy when used begins in How Is Bone Alive? — A Site That Builds as It Tears Down, a Warehouse the Body Draws On. Falls and fractures continue in Osteoporosis and Fractures — A Hollowed Pillar and the Moment of the Fall, and the link between weak front thigh muscles and knee disease in What Is Knee Osteoarthritis? — The Door Frame That Changes With the Hinge. The principles by which exercise becomes a treatment can be seen in Rehabilitation — Starting to Plan a Livable Home as the Fire Is Brought Under Control, and the other side of muscle and sugar processing in What Is Diabetes? — The Letter That Never Comes, the Letter That Isn't Read.

The cord that transmits the force generated by muscle to bone continues in What Is Tendinopathy? — The Rope That Follows Slowly, the Burden That Arrived First, and long-lasting pain in What Is Chronic Pain? — The Microphone and Amplifier, a Sound Ringing for Over Three Months.

Source Papers

• "Role of Skeletal Muscle in Insulin Resistance and Glucose Uptake." (2020) — PMID 32940941 — Skeletal muscle is the heaviest organ in the body and accounts for 80% of postprandial circulating glucose uptake, its role in peripheral insulin resistance.
• "The many actions of insulin in skeletal muscle, the paramount tissue determining glycemia." (2021) — PMID 33826918 — Muscle is the primary tissue for insulin-stimulated glucose disposal, increased insulin sensitivity after contraction and exercise, and discussion of defects that can cause muscle glucose uptake failure in obesity and type 2 diabetes (synthesizing human, rodent, and cellular studies).
• "Disuse-induced skeletal muscle atrophy in disease and nondisease states in humans: mechanisms, prevention, and recovery strategies." (2022) — PMID 35476500 — The balance between muscle protein synthesis and breakdown is the primary determinant of muscle mass, decreased mechanical load is the main external factor for atrophy, endocrine and inflammatory factors act synergistically in catabolic states, and age-related anabolic resistance has a greater impact during periods of inactivity.
• "The age-related loss of skeletal muscle mass and function: Measurement and physiology of muscle fibre atrophy and muscle fibre loss in humans." (2018) — PMID 30048806 — Muscle mass decreases by ~1% per year from middle age, with a loss of ~50% in severe cases by the 80s and 90s, muscle fiber atrophy and muscle fiber loss, with limited evidence for baseline protein metabolism changes and an underlying basis of anabolic resistance to everyday signals like activity and nutrition.
• "Nonuniform loss of muscle strength and atrophy during bed rest: a systematic review." (2021) — PMID 33703945 — 318 healthy adults, 5 to 120 days of bed rest, knee extensor strength and size decrease in a log curve (initial maximum), strength decreases much faster than atrophy in the first 2 weeks, atrophy explains ~79% of strength loss, and acute hospitalization of ≤5 days is sufficient for reductions in muscle mass, size, and maximal strength.
• "Protecting Skeletal Muscle with Protein and Amino Acid during Periods of Disuse." (2016) — PMID 27376322 — Short-term bed rest and disuse accelerate the loss of muscle mass, function, and glucose tolerance, disuse decreases muscle protein synthesis, older adults are more affected, and recommendations simply to increase protein and calorie intake are often unrealistic.
• "The Aging Muscle in Experimental Bed Rest: A Systematic Review and Meta-Analysis." (2021) — PMID 34422875 — 118 healthy older volunteers, 5 to 14 days of bed rest, 1.5 kg total lean mass decrease, large decrease in knee extension force (proportional to duration), leg muscle mass decrease of 0.86 kg in older adults versus 0.24 kg in young people.
• "The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study." (2006) — PMID 17077199 — 1,880 older adults for 3 years, leg muscle strength decreased by 2.6 to 4.1% per year, about 3 times leg lean mass (which fell by ~1% per year), maintaining or increasing muscle mass did not prevent the decline in strength, suggesting a loss of muscle quality.
• "Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review." (2012) — PMID 22934016 — In the same sample, strength loss is 2 to 5 times faster than muscle mass loss, strength loss is a more consistent risk for disability and mortality, and the concept of muscle quality.
• "Sarcopenia =/= dynapenia." (2008) — PMID 18772470 — An argument opposing the view that age-related strength loss is primarily driven by decreasing muscle mass, emphasizing instead changes in contractile properties and neural function (opinion paper).
• "Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort." (2006) — PMID 16456196 — 2,292 individuals aged 70 to 79 for an average of 4.9 years, quadriceps and grip strength are strongly associated with mortality, while muscle size shows no strong association.
• "Pathophysiology and mechanisms of primary sarcopenia (Review)." (2021) — PMID 34184088 — Lack of exercise, poor nutrition, and hormonal changes cause muscle protein breakdown to outpace synthesis, and sarcopenia is a major component of physical frailty and a muscle-specific concept.
• "Sarcopenia in older adults." (2012) — PMID 22955023 — Causes are multifactorial: neural decline, hormonal changes, inflammatory pathway activation, decreased activity, chronic disease, fat infiltration, and poor nutrition, with nutrition and exercise as interventions.
• "International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines." (2021) — PMID 34409961 — Aging phenotypes diverge between two extremes depending on physical activity, declines in muscle and cardiopulmonary function are significantly mitigated with sufficient exercise and activity, exercise is individualized and regulated, and exercise plays a primary prevention and treatment role in conditions like sarcopenia that lack effective pharmacotherapy.
• "Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment." (2020) — PMID 32033882 — Low grip strength (<28 kg for men, <18 kg for women), low physical performance (6m gait speed <1.0 m/s, SPPB ≤9, 5 chair stands ≥12 seconds), introduction of "possible sarcopenia" for primary care (only muscle strength or performance is low), with exercise and nutritional supplementation at the center of treatment.
• "Hand grip strength as a proposed new vital sign of health: a narrative review of evidences." (2024) — PMID 38195493 — Grip strength is reliably measured with a handheld dynamometer, reference values vary across populations and are lower in Asians and women, and it is associated with various diseases, hospitalization, and mortality (narrative review).
• "Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People." (2010) — PMID 20392703 — EWGSOP first criteria: low muscle mass + low muscle function (strength or performance).
• "Sarcopenia: revised European consensus on definition and diagnosis." (2019) — PMID 30312372 — EWGSOP2: Sarcopenia is a muscle disease, low muscle strength is the core characteristic, confirmed by muscle mass and quality, low performance indicates severe sarcopenia, common in older adults but can occur at earlier ages.
• "Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium." (2020) — PMID 32150289 — Low grip strength and slow gait speed in community-dwelling older adults predict falls, mobility limitation, hip fracture, and mortality respectively, DXA lean mass has no association, and consensus to include weakness and slowness in the definition.
• "Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia." (2014) — PMID 24461239 — AWGS first criteria, setting Asian reference values (grip strength <26 kg for men, <18 kg for women, etc.), with the limitation that most Asian studies are East Asian and cross-sectional.
• "The Diagnosis and Treatment of Sarcopenia and Sarcopenic Obesity." (2025) — PMID 39838543 — In a German population study, 7% had sarcopenia and 4.5% had sarcopenic obesity among those aged 65 and older, grip strength thresholds were <16 kg for women and <27 kg for men, and treatment consists of strength training and nutritional intervention.
• "Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis." (2022) — PMID 34816624 — 151 papers involving 692,056 people, prevalence ranges from 10% to 27% depending on criteria and cutoffs, higher in men under EWGSOP2 (11% vs. 2%) and higher in women under IWGS (17% vs. 12%), with severe sarcopenia at 2% to 9%.
• "Sarcopenia." (2024) — PMID 39300120 — Different definitions yield varying prevalence estimates but conservatively 5% to 10% in the general population, diagnosis is converging around muscle strength, and resistance exercise is the core of treatment though not suited for everyone.
• "The Conceptual Definition of Sarcopenia: Delphi Consensus from the Global Leadership Initiative in Sarcopenia (GLIS)." (2024) — PMID 38520141 — The first global conceptual definition addressing the lack of international consensus, classifying muscle mass, muscle strength, and muscle-specific strength as components and low physical performance as a consequence, upon which operational definitions will be developed.
• "Sarcopenia Is Associated with Mortality in Adults: A Systematic Review and Meta-Analysis." (2022) — PMID 34315158 — 57 papers (56 meta-analyses) involving 42,108 people, mortality risk ratio of 2.00, maintained regardless of population, definition, or follow-up period.
• "Sarcopenia and adverse health-related outcomes: An umbrella review of meta-analyses of observational studies." (2020) — PMID 32924316 — 30 observational meta-analyses with 54 outcomes, associated with falls, fractures, hospitalization, and mortality in older adults, with most evidence rated "low" or "very low".
• "Health outcomes of sarcopenia: a consensus report by the outcome working group of the Global Leadership Initiative in Sarcopenia (GLIS)." (2025) — PMID 40120052 — High certainty for association with reduced quality of life, falls and fractures, and mortality; moderate for instrumental activities of daily living; insufficient conclusions for hospitalization, nursing home admission, mobility disability, and basic activities of daily living due to a lack of longitudinal studies.
• "Sarcopenia, frailty and their prevention by exercise." (2019) — PMID 30176345 — Sarcopenia is a key component of the frailty syndrome, multi-component interventions including exercise and nutritional supplementation.
• "An Overview of Sarcopenia: Focusing on Nutritional Treatment Approaches." (2025) — PMID 40218995 — Secondary sarcopenia can stem from physical inactivity, poor nutrition, endocrine disorders, neurodegenerative diseases, inflammation, and cachexia.
• "Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management." (2019) — PMID 31641726 — Strong recommendation to evaluate treatable causes of weight loss and fatigue (depression, anemia, hypotension, hypothyroidism, B12 deficiency), strong recommendation for multi-component physical activity including resistance exercise as primary treatment, conditional recommendation for protein and calorie supplementation in weight loss or malnutrition, no recommendation for vitamin D supplementation, and current pharmacotherapy not recommended.
• "Effects of Resistance Training on Muscle Size and Strength in Very Elderly Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials." (2020) — PMID 32740889 — 22 randomized trials in adults aged 75 and older, increased strength (effect size 0.97) and muscle size, increased strength even above age 80, no significant difference in grip strength, and minimal adverse events reported.
• "Progressive resistance strength training for improving physical function in older adults." (2009) — PMID 19588334 — Cochrane review of 121 trials involving 6,700 people, large effect on strength, medium to large effect on chair rise, 0.08 m/s gait speed, small improvement in physical capacity, poor adverse event recording, musculoskeletal discomfort common, serious events rare and not reported as directly related to exercise, and caution needed when applying to clinical populations.
• "Resistance exercise as a treatment for sarcopenia: prescription and delivery." (2022) — PMID 35150587 — Resistance exercise is recommended as a first-line treatment, but evidence of benefit in older adults with sarcopenia is much less than in healthy older adults.
• "Efficacy of Exercise on Muscle Function and Physical Performance in Older Adults with Sarcopenia: An Updated Systematic Review and Meta-Analysis." (2022) — PMID 35805870 — 23 papers involving 1,252 people, exercise improves grip strength (MD 2.38 kg), knee extension force, gait speed, and functional mobility, slight increase in leg muscle mass (MD 0.28 kg), no significant effect on lean mass, combined limbs, or arm muscle mass, and resistance or combined exercise increases strength, whereas aerobic exercise does not.
• "Exercise for sarcopenia in older people: A systematic review and network meta-analysis." (2023) — PMID 37057640 — 42 papers involving 3,728 people with a median follow-up of 12 weeks, resistance exercise (± nutrition) and resistance + aerobic + balance are most effective for improving quality of life compared to routine care (high to moderate certainty), adding nutrition to exercise yields a greater grip strength effect with similar functional outcomes.
• "Optimal resistance training prescriptions to improve muscle strength, physical function, and muscle mass in older adults diagnosed with sarcopenia: a systematic review and meta-analysis." (2025) — PMID 41212331 — 24 papers involving 951 people, resistance exercise likely improves muscle strength and physical function, but the magnitude of improvement does not exceed the minimal important difference, yielding little to no clinical benefit, with no improvement in limb muscle mass.
• "Systematic review and meta-analysis of protein intake to support muscle mass and function in healthy adults." (2022) — PMID 35187864 — 74 randomized trials in healthy adults, increased protein intake slightly increases lean mass and lower-body strength in individuals engaging in resistance training, minimal effect on physical function tests, and unclear effect on grip strength.
• "Nutritional interventions to improve muscle mass, muscle strength, and physical performance in older people: an umbrella review of systematic reviews and meta-analyses." (2021) — PMID 32483625 — Belgian Society of Gerontology and Geriatrics, evidence level mostly low to moderate, leucine has the best evidence for muscle mass in older adults with sarcopenia, protein supplementation on top of resistance training is recommended for increasing muscle mass and strength (especially for obesity and over 24 weeks), and no effect reported on sarcopenia itself.
• "Sarcopenia." (2017) — PMID 28689564 — Sarcopenia increases the risk of falls, fractures, dependency, hospitalization, and mortality, and current treatment centers on optimizing nutritional status (especially protein and vitamin D) and resistance exercise.
• "A Review of Sarcopenia Pathophysiology, Diagnosis, Treatment and Future Direction." (2022) — PMID 35535373 — Resistance exercise is the standard non-pharmacological treatment, no FDA-approved medications exist for sarcopenia, and various drugs have been tested with varying efficacy.
• "Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement." (2022) — PMID 35196654 — Sarcopenic obesity is the coexistence of excess fat and low muscle mass and function, sarcopenia is common in obesity, muscle function should be assessed first and confirmed by body composition, and lack of a unified definition has made it difficult to establish prevalence and clinical significance.
• "Sarcopenic obesity and weight loss-induced muscle mass loss." (2025) — PMID 40296814 — Weight loss from incretin-based obesity drugs results in variable but significant decreases in lean mass, impact on muscle mass and function is uncertain, clinical significance is debated, and adequate protein and resistance exercise are key to mitigating loss.
• "Epidemiology of sarcopenia: A narrative review." (2025) — PMID 40718350 — Prevalence estimates vary widely depending on the definition, certainty of risk factor evidence is low to moderate, and longitudinal and interventional studies are needed to elucidate causal pathways.